Artificial intelligence (AI) may one day play a larger role in medicine than the online symptom checkers available today. But these “AI doctors” may need to get more personal than human doctors to increase patient satisfaction, according to a study led by researchers at Penn State.
Tirzepatide cuts diabetes risk by 90% in obese patients, study shows
Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than
November 26, 2024